Exam 2: Neurotransmitters hoe Flashcards
Small molecule neurotransmitter synthesis and transport:
- Synthesis occurs locally within axon terminals
- The enzymes needed to synthesize the neurotransmitters are sent from the cell body to the axon terminals by slow axonal transport
- The neurotransmitter is then loaded into vesicles at the terminal—the vesicles are visually clear (i.e. small clear-core vesicles
Peptide synthesis and transport:
- Synthesis occurs in the cell body
- The peptide is put in to vesicles and sent from the cell body to the axon terminals by fast axonal transport
- The vesicles get to the axon terminal and then are released once the signal is sent
Monoamines
The monoamines dopamine (DA), norepinephrine (NE) and serotonin (5HT) are heavily implicated in addiction, drugs of abuse and therapeutic drugs
Dopamine and Norepinephrine Percursor and Enzymes
- tyrosine
- tyrosine hydroxylase (TH)
- aromatic amino acid decarboxylase (AADC)
- Tyrosine is converted to DOPA by TH and DOPA is then converted to dopamine by AADC
Storage of DA and NE
- After synthesis, catecholamines are packaged into vesicles
- A specific transporter in the vesicle membrane recognizes monoamines – the vesicular monoamine transporter (VMAT)
Release of DA and NE: VMAT Blockage
- VMAT can be blocked by the drug reserpine, which is used to treat high blood pressure. Blocking VMAT prevents synaptic vesicles filling, which decreases neurotransmitter release
Release of DA and NE
- Catecholamine release is inhibited by autoreceptors on neuron cell bodies, terminals, and dendrites.
- The autoreceptors enhance the opening voltage-gated K+ channels. This shortens the duration of action potentials and reduces the Ca2+ influx and, thus, vesicles exocytosis.
2 major forms of Inactivation for DA and NE
Enzymatic and Reuptake
Inactivation for DA and NE: Enzymatic
- Enzymatic : two major catecholamine enzymatic inactivators: catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO).
- MAO inhibitors are used to treat depression
- COMT inhibitors are given with Parkinson’s disease treatments to increase their effectiveness
Inactivation for DA and NE: Reuptake
- Transporter-There are two types of catecholamine transporters: dopamine transporter (DAT) and norepinephrine transporter (NET)
- Psychostimulants, such as cocaine and amphetamines, block catecholamine transporters—this increases synaptic catecholamine levels
- Antidepressants also work, in part, by blocking norepinephrine reuptake
Receptors for DA
- DA uses five receptor subtypes, D1 to D5.
- All are metabotrophic : they interact with G proteins and function via second messengers.
- Nearly all current antischizophrenic drugs are D2 receptor antagonists.
- Generally excitatory receptors
Receptors for NE
- NE receptors are also metabotropic
- Psychoactive drugs targeting NE often involve working memory, such as clonidine.
Function of DA
Dopamine signaling plays a role in reward-based learning and motor control
Function of NE
Norepinephrine plays a role in arousal, cognition, emotion, attention and memory
Function of 5HT
Serotonin is involved in learning and memory, anxiety, and other emotional behaviors.
DA Neural Circuits
- Nigrostriatal pathway: substantia nigari to the striatum. Function is for voluntary movement, and neurons in this circuit are lost in Parkinson’s disease
- Mesolimbic pathway: ventral tegmental area to the limbic system. Function is for reward and addiction
- Mesocortical pathway : ventral tegmental area to the prefrontal cortex. Function is for motivation and emotional responses
NE Neural Circuits
- The locus coeruleus (LC) in the pons contains a dense collection of NE neuronal cell bodies. These neurons project widely to all areas of the cerebral cortex, cerebellum and spinal cord
- Drugs that target NE have broad effects, from the CNS to the PNS
Serotonin Precursor and Enzymes
- tryptophan
- Tryptophan is converted to serotonin in two steps involving two enzymes: tryptophan hydroxylase (TPH) and AADC
Serotonin Storage and Release
- VMAT is responsible for loading serotonin in to vesicles
- Autoreceptors on axon terminals regulate release and synthesis of serotonin
- MDMA (aka ecstasy) stimulates 5HT release
Serotonin Inactivation
- Reuptake: serotonin reuptake transporter (SERT) is target of SSRIs in depression. Cocaine also blocks SERT.
- Enzymatic degradation: monoamine oxidase (MAO)
Serotonin Receptors
- Most 5HT receptors are metabotropic and generally have inhibitory functions, but some are excitatory as well
- Hallucigenic drugs often target 5HT, for example LSD stimulates a 5HT receptor
- Newer drugs to treat schizophrenia also target and block 5HT receptors (clozapine and Risperdal)
Serotonin Neural Circuits
- Almost all serotonergic neurons in the CNS are found along the midline of the brainstem, associated with the raphe nuclei.
- They project widely to areas in the cerebral cortex, including the hippocampus and amygdala